Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIOD-531 vs Humalog Mix 75/25 in Type 2 Diabetes
NCT02446028Phase 2Suspended
- Sponsor
- Biodel Inc.
- Start
- May 2015
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Insulin (recombinant human, concentrated, BIOD-531 formulation) in type 2 diabetes mellitus (T2DM), sponsored by Biodel Inc.. Started May 2015; status: suspended.
02
Drugs
Insulin (recombinant human, concentrated, BIOD-531 formulation)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02446028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446028.